Integralis

Company Overview

Snapshot

Founded in January 2006 by Dan Sadeh Hochstadter, Integralis operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing its AI diagnostic system for premature newborns.

Business overview

Integralis is a digital health company specializing in medical care for premature infants. The company has developed an AI diagnostic system designed to predict sepsis in premature newborns days before clinical symptoms manifest. Its core technology aims to detect late-onset sepsis 36 to 48 hours in advance, thereby improving patient outcomes, reducing hospitalization costs, and minimizing antibiotic use. Integralis operates within the Health Tech & Life Sciences sector, specifically targeting the digital healthcare and medical diagnostics markets with its B2B business model.

Company Intelligence Q&A

What is Integralis' primary focus?

Integralis is focused on developing an AI diagnostic system to predict sepsis in premature newborns days before clinical presentation, aiming to save lives and reduce hospitalization costs.

When was Integralis founded?

Integralis was founded in January 2006.

Who founded Integralis?

Integralis was founded by Dan Sadeh Hochstadter.

What is the primary product offered by Integralis?

Integralis offers a product called Inbar Ralis, which is an AI diagnostic system for predicting sepsis in premature infants.

In which sectors does Integralis operate?

Integralis operates in the Health Tech & Life Sciences sector, with a focus on Digital Healthcare and Digital Medical Diagnostics.